MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Perrigo Company plc ROCE Ratio 2011-2026 | PRGO
Annual ROCE Ratio Perrigo Company plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.31 | 1.65 | 0.8 | 4.64 | 2.62 | 4.17 | 5.1 | 6.93 | 5.5 | 4.09 | 3.14 | 13.21 | 17.14 | 17.44 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.44 | 0.8 | 6.27 |
Quarterly ROCE Ratio Perrigo Company plc
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.68 | 2.69 | 1.89 | -0.08 | 0.56 | 0.37 | 1.24 | 1.7 | 2.04 | 1.75 | 1.11 | 0.5 | 5.42 | 10.0 | 8.71 | 4.08 | 4.85 | 0.71 | 2.69 | 2.25 | 2.8 | 2.57 | 2.5 | 2.12 | 0.83 | -1.0 | -0.55 | 1.37 | 2.96 | 5.84 | 6.3 | 4.31 | -7.89 | -21.68 | -21.61 | -12.59 | -11.55 | 1.7 | 1.31 | 3.31 | 4.53 | 4.56 | 5.93 | 5.88 | 5.34 | 11.92 | 11.29 | 136335888.08 | 136335887.4 | 136335879.75 | 136335877.86 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 136335888.08 | -21.68 | 10693011.74 |
ROCE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-190.63 | - | 7.5 % | $ 6.35 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | USA |
 |
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M | USA |
 |
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M | USA |
 |
Canopy Growth Corporation
CGC
|
-24.04 | $ 1.14 | -4.62 % | $ 123 M |  Canada |
 |
Cronos Group
CRON
|
-10.43 | $ 2.56 | 1.24 % | $ 1.35 B | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.06 | $ 4.74 | 1.94 % | $ 66.6 M | USA |
 |
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M |  Irlanda |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-39.6 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-85.61 | - | 2.45 % | $ 38.1 M | Canada |
 |
Evoke Pharma
EVOK
|
-184.26 | - | - | $ 36.6 M | USA |
 |
DURECT Corporation
DRRX
|
-249.5 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
-111.87 | $ 11.08 | 0.82 % | $ 567 M | USA |
 |
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | USA |
 |
Evolus
EOLS
|
-623.16 | $ 5.05 | -2.88 % | $ 313 M | USA |
 |
Harrow Health
HROW
|
0.61 | $ 47.49 | -0.86 % | $ 1.55 B | USA |
 |
China Pharma Holdings
CPHI
|
-59.23 | $ 1.25 | - | $ 21.8 M |  China |
 |
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | USA |
 |
OrganiGram Holdings
OGI
|
-35.84 | $ 1.62 | 0.62 % | $ 402 M | Canada |
 |
Bausch Health Companies
BHC
|
-94.23 | $ 6.75 | -3.3 % | $ 2.46 B | Canada |
 |
Neoleukin Therapeutics
NLTX
|
-29.88 | - | - | $ 193 M | Canada |
 |
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | USA |
 |
Sundial Growers
SNDL
|
-68.48 | $ 1.58 | -2.17 % | $ 3.37 M | Canada |
 |
Organogenesis Holdings
ORGO
|
-0.49 | $ 3.64 | -3.96 % | $ 479 M | USA |
 |
Pacira BioSciences
PCRX
|
-9.43 | $ 19.43 | 1.38 % | $ 899 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-57.41 | $ 21.51 | 0.14 % | $ 2.05 B |  France |
 |
PetIQ
PETQ
|
5.46 | - | 1.64 % | $ 400 M | USA |
 |
Aurora Cannabis
ACB
|
-23.09 | $ 4.14 | -2.13 % | $ 86.3 M | Canada |
 |
ProPhase Labs
PRPH
|
32.97 | - | - | $ 5.07 M | USA |
 |
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | USA |
 |
Rockwell Medical
RMTI
|
-31.33 | $ 1.22 | 27.44 % | $ 28.5 M | USA |
 |
Radius Health
RDUS
|
21.53 | - | - | $ 1.42 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-84.11 | $ 3.33 | 1.06 % | $ 4.13 M | USA |
 |
Relmada Therapeutics
RLMD
|
-121.49 | $ 3.93 | 5.01 % | $ 118 M | USA |
 |
OptiNose
OPTN
|
26.27 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
-176.47 | $ 12.04 | 4.88 % | $ 855 M | USA |
 |
Tilray
TLRY
|
-41.31 | $ 8.74 | -7.62 % | $ 5.4 B | Canada |
 |
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-81.9 | $ 5.59 | 2.19 % | $ 228 M | USA |
 |
SCYNEXIS
SCYX
|
99.6 | $ 0.65 | -0.68 % | $ 31.1 M | USA |
 |
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | USA |
 |
Veru
VERU
|
-114.23 | $ 2.53 | -5.95 % | $ 341 M | USA |
 |
TherapeuticsMD
TXMD
|
-29.1 | $ 2.55 | 14.39 % | $ 26.6 M | USA |
 |
Viatris
VTRS
|
7.66 | $ 12.66 | -1.59 % | $ 15.3 B | USA |
 |
Zomedica Corp.
ZOM
|
-13.16 | - | -0.21 % | $ 98 M | USA |
 |
cbdMD
YCBD
|
-235.96 | $ 0.83 | -9.94 % | $ 3.58 M | USA |